Literature-based compound profiling: Application to toxicogenomics

Pharmacogenomics

Volumn 8, Issue 11, 2007, Pages 1521-1534

  Frijters, Raoul ^a   Verhoeven, Stefan ^b   Alkema, Wynand ^b   van Schaik, René ^a,b   Polman, Jan ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NV ORGANON   (Netherlands)

Author keywords

Compound profiling; Diethylhexylphthalate; Dimethylnitrosamine; Gene expression; Literature based networks; Methapyrilene; Microarray; Profiling; Text mining; Toxicogenomics

Indexed keywords

CARCINOGEN; DIMETHYLNITROSAMINE; METHAPYRILENE; PEROXISOME PROLIFERATOR; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; XENOBIOTIC AGENT;

APOPTOSIS; ARTICLE; CELL AGING; CELL METABOLISM; DATA MINING; DNA DAMAGE; DNA FINGERPRINTING; DOWN REGULATION; DRUG METABOLISM; ENERGY METABOLISM; EVIDENCE BASED MEDICINE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOTOXICITY; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LIPID METABOLISM; LIVER TOXICITY; MEDLINE; MICROARRAY ANALYSIS; MUTAGENESIS; NONHUMAN; OXIDATIVE STRESS; STEROID METABOLISM; SYSTEMATIC REVIEW; TOXICOGENETICS; UPREGULATION;

ALGORITHMS; ANIMALS; CARCINOGENS; DATABASES, BIBLIOGRAPHIC; DATABASES, GENETIC; GENE EXPRESSION PROFILING; LIVER; MEDLINE; MUTAGENS; NATURAL LANGUAGE PROCESSING; PEROXISOME PROLIFERATORS; RATS; TOXICOGENETICS; VOCABULARY, CONTROLLED;

RATTUS;

EID: 37349053408     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/14622416.8.11.1521     Document Type: Article

References (55)

1. Walmsley RM: Genotoxicity screening: the slow march to the future. Expert Opin. Drug Metab. Toxicol. 1(2), 261-268 (2005).
2. Afshari CA, Nuwaysir EF, Barrett JC: Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safety evaluation. Cancer Res. 59(19), 4759-4760 (1999).
3. Nuwaysir EF, Bittner M, Trent J, Barrett JC, Afshari CA: Microarrays and toxicology: the advent of toxicogenomics. Mol. Carcinog. 24(3), 153-159 (1999).
4. Castle AL, Carver MP, Mendrick DL: Toxicogenomics: a new revolution in drug safety. Drug Discov Today 7(13), 728-736 (2002).
5. Subramanian A, Tamayo P. Mootha VK et al.: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102(43), 15545-15550 (2005).
6. Yi M, Horton JD, Cohen JC, Hobbs HH, Stephens RM: WholePathwayScope: a comprehensive pathway-based analysis tool for high-throughput data. BMC Bioinformatics 7, 30 (2006).
7. Currie RA, Bombail V, Oliver JD et al.: Gene ontology mapping as an unbiased method for identifying molecular pathways and processes affected by toxicant exposure: application to acute effects caused by the rodent non-genotoxic carcinogen diethylhexylphthalate. Toxicol Sci. 86(2), 453-469 (2005).
8. Jenssen TK, Laegreid A, Komorowskl J, Hovig E: A literature network of human genes for high-throughput analysis of gene expression. Nat. Genet. 28(1), 21-28 (2001).
9. Jelier R, Jenster G, Dorssers LC et al.: Text-derived concept profiles support assessment of DNA microarray data for acute myeloid leukemia and for androgen receptor stimulation. BMC Bioinformatics 8, 14 (2007).
10. Chaussabel D, Sher A: Mining microarray expression data by literature profiling. Genome Biol. 3(10), research0055.1-research0055.16 (2002).
11. Chagoyen M, Carmona-Saez P, Shatkay H, Carazo JM, Pascual-Montano A: Discovering semantic features in the literature: a foundation for building functional associations. BMC Bioinformatics 7, 41 (2006).
12. Kuffher R, Fundel K, Zimmer R: Expert knowledge without the expert: integrated analysis of gene expression and literature to derive active functional contexts. Bioinformatics 21(Suppl. 2), ii259-ii267 (2005).
13. Glenisson P, Antal P, Mathys J, Moreau Y, De Moor B: Evaluation of the vector space representation in text-based gene clustering. Pac. Symp. Biocomput. 391-402 (2003).
14. Rubinstein R, Simon I: MILANO - custom annotation of microarray results using automatic literature searches. BMC Bioinformatics 6, 12 (2005).
15. Blaschke C, Oliveros JC, Valencia A: Mining functional information associated with expression arrays. Funct. Integr. Genomics 1(4), 256-268 (2001).
16. Alako BT, Veldhoven A, van Baal S et al.: CoPub Mapper: mining MEDLINE based on search term co-publication. BMC Bioinformatics 6, 51 (2005).
17. Ding J, Berleant D, Nettleton D, Wurtele E: Mining MEDLINE: abstracts, sentences, or phrases? Pac. Symp. Biocomput. 7, 326-337 (2002).
18. Ellinger-Ziegelbauer H, Stuart B, Wahle B, Bomann W, Ahr HJ: Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver. Mutat. Res. 575(1-2), 61-84 (2005).
19. Ellinger-Ziegelbauer H, Stuart B, Wahle B, Bomarm W, Ahr HJ: Characteristic expression profiles induced by genotoxic carcinogens in rat liver. Toxicol. Sci. 77(1), 19-34 (2004).
20. Jolly RA, Goldstein KM, Wei T et al.: Pooling samples within microarray studies: a comparative analysis of rat liver transcription response to prototypical toxicants. Physiol. Genomics 22(3), 346-355 (2005).
21. Maglott D, Ostell J, Pruitt KD, Tatusova T: Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res. 35(Database issue), D26-D31 (2007).
22. Parkinson H, Kapushesky M, Shojatalab M et al.: ArrayExpress - a public database of microarray experiments and gene expression profiles. Nucleic Acids Res. 35(Database issue), D747-D750 (2007).
23. Shannon P, Markiel A, Ozier O et al.: Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13(11), 2498-2504 (2003).
24. Rusyn I, Peters JM, Cunningham ML: Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver. Crit. Rev. Toxicol. 36(5), 459-479 (2006).
25. Gonzalez FJ, Peters JM, Cattley RC: Mechanism of action of the nongenotoxic peroxisome proliferators: role of the peroxisome proliferator-activator receptor α. J Natl Cancer Inst. 90(22), 1702-1709 (1998).
26. Brunnemann KD, Fink W, Moser F: Analysis of volatile N-nitrosamines in mainstream and sidestream smoke from cigarettes by GLC-TEA. Oncology 37(4), 217-222 (1980).
27. Barrows LR: Methylation of DNA guanine via the 1-carbon pool in dimethylnitrosamine-treated rats. Mutat. Res. 173(1), 73-79 (1986).
28. George J, Rao KR, Stern R, Chandrakasan G: Dimethylnitrosamine-induced liver injury in rats: the early deposition of collagen. Toxicology 156 (2-3), 129-138 (2001).
29. Gombar CT, Zubroff J, Strahan GD, Magee PN: Measurement of 7-methylguanine as an estimate of the amount of dimethylnitrosamine formed following administration of aminopyrine and nitrite to rats. Cancer Res. 43(11), 5077-5080 (1983).
30. Schook LB, Lockwood JF, Yang SD, Myers MJ: Dimethyinitrosamine (DMN)- induced IL-1 beta, TNF-α, and IL-6 inflammatory cytokine expression. Toxicol. Appl. Pharmacol. 116(1), 110-116 (1992).
31. Jin YL, Enzan H, Kuroda N et al.: Tissue remodeling following submassive hemorrhagic necrosis in rat livers induced by an intraperitoneal injection of dimethylnitrosamine. Virchows Arch. 442(1), 39-47 (2003).
32. Jin YL, Enzan H, Kuroda N et al.: Vascularization in tissue remodeling after rat hepatic necrosis induced by dimethylnitrosamine. Med. Mol. Morphol. 39(1), 33-43 (2006).
33. Sato M, Suzuki S, Senoo H: Hepatic stellate cells: unique characteristics in cell biology and phenotype. Cell Struct. Funct. 28(2), 105-112 (2003).
34. Guyot C, Lepreux S, Combe C et al.: Hepatic fibrosis and cirrhosis: the (myo) fibroblastic cell subpopulations involved. Int. J. Biochem. Cell Biol. 38(2), 135-151 (2006).
35. Noguchi S, Inukai T, Kuno T, Tanaka C: The suppression of olfactory bulbectomy-induced muricide by antidepressants and antihistamines via histamine H1 receptor blocking. Physiol. Behav. 51(6), 1123-1127 (1992).
36. Hamadeh HK, Knight BL, Haugen AC et al.: Methapyrilene toxicity: anchorage of pathologic observations to gene expression alterations. Toxicol. Pathol. 30(4), 470-482 (2002).
37. Mirsalis JC: Genotoxicity, toxicity, and carcinogenicity of the antihistamine methapyrilene. Mutat. Res. 185(3), 309-317 (1987).
38. Steinmetz KL, Tyson CK, Meierhenry EF, Spalding JW, Mirsalis JC: Examination of genotoxicity, toxicity and morphologic alterations in hepatocytes following in vivo or in vitro exposure to methapyrilene. Carcinogenesis 9(6), 959-963 (1988).
39. Casciano DA, Talaska G, Clive D: The potent hepatocarcinogen methapyrilene induces mutations in L5178Y mouse lymphoma cells in the apparent absence of DNA adduct formation. Mutat. Res. 263(2), 127-132 (1991).
40. Ratra GS, Powell CJ, Park BK, Maggs JL, Cottrell S: Methapyrilene hepatotoxicity is associated with increased hepatic glutathione, the formation of glucuronide conjugates, and enterohepatic recirculation. Chem. Biol. Interact. 129(3), 279-295 (2000).
41. Brennan LM, Creasia DA: The effects of methapyrilene hydrochloride on hepatocarcinogenicity and pentobarbital-induced sleeping time in rats and mice. Toxicol. Appl. Pharmacol. 66(2), 252-258 (1982).
42. Lijinsky W, Knutsen G, Reuber MD: Failure of methapyrilene to induce tumors in hamsters or guinea pigs. J. Toxicol. Environ. Health 12(4-6), 653-657 (1983).
43. Cunningham ML: Role of increased DNA replication in the carcinogenic risk of nonmutagenic chemical carcinogens. Mutat. Res. 365(1-3), 59-69 (1996).
44. 2+ channel blocker verapamil. Toxicology 130(2-3), 79-93 (1998).
45. Pastore A, Federici G, Bertini E, Piemonte F: Analysis of glutathione: implication in redox and detoxification. Clin. Chim. Acta 333(1), 19-39 (2003).
46. Rost D, Konig J, Weiss G et al.: Expression and localization of the multidrug resistance proteins MRP2 and MRP3 in human gallbladder epithelia. Gastroenterology 121(5), 1203-1208 (2001).
47. Schinkel AH: The physioiogical function of drug-transporting P-glycoproteins. Semin. Cancer Biol. 8(3), 161-170 (1997).
48. Cohen SM: Role of cell proliferation in regenerative and neoplastic disease. Toxicol. Lett. 82-83, 15-21 (1995).
49. Anderson ME: Glutathione: an overview of biosynthesis and modulation. Chem. Biol. Interact. 111-112, 1-14 (1998).
50. Kang YJ: Metallothionein redox cycle and function. Exp. Biol. Med. (Maywood) 231(9), 1459-1467 (2006).
51. Peng L, Mundada L, Stomel JM et al.: Induction of heme oxygenase-1 expression inhibits platelet-dependent thrombosis. Antioxid. Redox Signal. 6(4), 729-735 (2004).
52. Lampe MA, Kammerer RC: Cytochrome P-450 dependent binding of methapyrilene to DNA in vitro. Carcinogenesis 8(10), 1525-1529 (1987).
53. Lampe MA, Kammerer RC: Species differences in the metabolism and macromolecular binding of methapyrilene: a comparison of rat, mouse and hamster Xenobiotica 20(12), 1269-1280 (1990).
54. 2+ wave propagation. Cell Death Differ 11(12), 1265-1276 (2004).
55. Gramantieri L, Chieco P, Giovannini C et al.: GADD45-α expression in cirrhosis and hepatocellular carcinoma: relationship with DNA repair and proliferation. Hum. Pathol. 36(11), 1154-1162 (2005).